BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24403586)

  • 21. HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms.
    Reszka-Blanco NJ; Sivaraman V; Zhang L; Su L
    J Virol; 2015 Aug; 89(15):7604-11. PubMed ID: 25972534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.
    Zhou T; Dang Y; Baker JJ; Zhou J; Zheng YH
    Retrovirology; 2012 Nov; 9():93. PubMed ID: 23134572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5.
    Staropoli I; Dufloo J; Ducher A; Commere PH; Sartori-Rupp A; Novault S; Bruel T; Lorin V; Mouquet H; Schwartz O; Casartelli N
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.
    Willey RL; Maldarelli F; Martin MA; Strebel K
    J Virol; 1992 Dec; 66(12):7193-200. PubMed ID: 1433512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations.
    Hikichi Y; Van Duyne R; Pham P; Groebner JL; Wiegand A; Mellors JW; Kearney MF; Freed EO
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement.
    Alsahafi N; Anand SP; Castillo-Menendez L; Verly MM; Medjahed H; Prévost J; Herschhorn A; Richard J; Schön A; Melillo B; Freire E; Smith AB; Sodroski J; Finzi A
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function.
    Nguyen HT; Alsahafi N; Finzi A; Sodroski JG
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.
    Zhang X; Shi J; Qiu X; Chai Q; Frabutt DA; Schwartz RC; Zheng YH
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
    Heredia JD; Park J; Choi H; Gill KS; Procko E
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
    Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redox-dependent protein quality control in the endoplasmic reticulum: folding to degradation.
    Hagiwara M; Nagata K
    Antioxid Redox Signal; 2012 May; 16(10):1119-28. PubMed ID: 22229892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface translocator protein 18 kDa (TSPO) localization on immune cells upon stimulation with LPS and in ART-treated HIV
    Blevins LK; Crawford RB; Azzam DJ; Guilarte TR; Kaminski NE
    J Leukoc Biol; 2021 Jul; 110(1):123-140. PubMed ID: 33205494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV envelope tail truncation confers resistance to SERINC5 restriction.
    Haider T; Snetkov X; Jolly C
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.
    von Bredow B; Arias JF; Heyer LN; Gardner MR; Farzan M; Rakasz EG; Evans DT
    J Virol; 2015 Oct; 89(20):10648-55. PubMed ID: 26269175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages.
    Siddiqui R; Suzu S; Ueno M; Nasser H; Koba R; Bhuyan F; Noyori O; Hamidi S; Sheng G; Yasuda-Inoue M; Hishiki T; Sukegawa S; Miyagi E; Strebel K; Matsushita S; Shimotohno K; Ariumi Y
    PLoS Pathog; 2018 Nov; 14(11):e1007372. PubMed ID: 30496280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Lethality and Loss of Env Protein Expression Induced by Single Synonymous Substitutions in the Virus Genome Intronic-Splicing Silencer.
    Jordan-Paiz A; Nevot M; Lamkiewicz K; Lataretu M; Franco S; Marz M; Martinez MA
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic.
    Bouvin-Pley M; Beretta M; Moreau A; Roch E; Essat A; Goujard C; Chaix ML; Moiré N; Martin L; Meyer L; Barin F; Braibant M
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.